Target intelligence / Profile preview

Immunoglobulin class switch recombination (CSR)

Target
CSR
Molecular classification
Other
01

Overview

Immunoglobulin class switch recombination (CSR), also known as antibody class switching or isotype switching, is a biological process that occurs in activated B cells, allowing them to change the class of antibody they produce (from IgM and IgD to IgG, IgA, or IgE) without altering the antigen specificity. This process involves a deletional recombination event between DNA switch (S) regions that are located upstream of the immunoglobulin heavy chain constant region genes. CSR is initiated by activation-induced cytidine deaminase (AID), which deaminates cytosines in S regions, leading to DNA breaks and recombination facilitated by DNA repair enzymes. The process is essential for a robust and tailored humoral immune response, enabling antibodies to interact with different effector molecules to combat pathogens more effectively. Dysregulation of CSR can contribute to immunodeficiencies or autoimmunity, but it is not itself a direct therapeutic target as it is a biological mechanism rather than a single molecule, receptor, or enzyme[1][2][3][6].

Other names
antibody class switchingimmunoglobulin class switchingisotype switchingisotypic commutation
02

Biological functions

Immune responseAntibody diversification
03

Disease associations

Other (Autoimmunity, Immunodeficiency—indirectly by dysregulation of the process)

Beyond the preview

Go deeper on Immunoglobulin class switch recombination (CSR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin class switch recombination (CSR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call